Register for email alerts and news feeds:
This journal | BMJ Group
rss
Emergency Medicine Journal 2008;25:156-157; doi:10.1136/emj.2006.038828
© 2008 BMJ Publishing Group Ltd and the College of Emergency Medicine.

SHORT REPORT

Epistaxis: when are coagulation studies justified?

M S Awan, M Iqbal and S Z Imam

Section of Otolaryngology Head and Neck Surgery, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan

Correspondence to:
Dr M S Awan, Department of Otolaryngology Head and Neck Surgery, Aga Khan University Hospital, Stadium Road, PO Box 3500, Karachi 74800, Pakistan; sohail.awan{at}aku.edu

ABSTRACT

Background: Epistaxis is a common emergency in otolaryngology. There is some evidence questioning the use of routine coagulation studies (prothrombin time and activated partial thromboplastin time (APTT)) in these patients, but this practice continues in most centres.

Aim: To identify groups of patients likely to present with coagulation abnormalities.

Methods: Charts of all patients aged >14 years with epistaxis, requiring admission to Aga Khan University Hospital, Karachi, Pakistan, through the emergency department between January 2002 and December 2005, were retrospectively reviewed for the presence of comorbid conditions and coagulation abnormalities. Deranged coagulation was defined as an APTT of >7 s above control or an international normalised ratio >1.5. Analysis was carried out using SPSS V.13.0.

Results: All 108 patients were included in the study (male patients, 71.3%; female patients, 28.7%; mean age 40.4 years). Only 49 patients had an associated condition that could potentially cause epistaxis. Of these, the coagulation profiles of 10 patients were deranged, which included 6 patients receiving anticoagulant treatment, 2 with chronic active hepatitis, 1 with liver cancer and 1 with haemophilia.

Conclusion: Routine coagulation screening of all patients with epistaxis is of little value and only adds to treatment costs and emergency room occupancy times. Comorbid conditions such as hypertension or cases with thrombocytopenia do not merit coagulation screening. However, coagulation studies are justified in patients receiving anticoagulant treatment and those with known coagulopathy or chronic liver disease.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Schlosser, R. J. (2009). Epistaxis. NEJM 360: 784-789 [Full Text]  

eLetters:

Read all eLetters

Methodology Matters?
Mark F Buckley, et al.
EMJ Online, 23 Apr 2008 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

 

The journal is co-owned by and the official journal of College of Emergency Medicine

Official journal of British Association for Immediate Care: BASICS, Faculty of Pre-Hospital Care, Irish Society for Immediate Care and Swedish Society for Emergency Medicine: SweSEM

Emergency Medicine Jobs

Emergency Medicine Jobs